Medications starting with
Poland-
It is used in adults and children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections associated with skin infections. In adults, it is also used for the treatment of bloodstream infections and infections of the endocardium caused by Staphylococcus aureus.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 500 mg ATC code: J01XX09
Manufacturer: Accord Healthcare Poland Limited Liability Company
-
The medicine is used in adults, as well as in children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and related bloodstream infections. In adults, it is also used to treat bloodstream infections and infections of the tissues lining the heart chambers (including valves) caused by the bacterium Staphylococcus aureus.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 500 mg ATC code: J01XX09
Manufacturer: Accord Healthcare Polska Ltd. Laboratori Fundació Dau Pharmadox Healthcare Ltd.
-
The medicinal product is used in adults, as well as in children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections associated with skin infections. In adults, it is also used for the treatment of heart infections (endocarditis) and bloodstream infections caused by Staphylococcus aureus bacteria.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 350 mg ATC code: J01XX09
-
The medicinal product is used in adults and children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections associated with these infections. In adults, it is also used to treat infections of the endocardium and bloodstream infections caused by Staphylococcus aureus bacteria.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 350 mg ATC code: J01XX09
Manufacturer: Fosun Pharma Sp. z o.o.
-
The medicinal product is used in adults, children, and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and related bloodstream infections. In adults, it is also used to treat bloodstream infections and infections of the endocardium (including heart valves) caused by Staphylococcus aureus.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 500 mg ATC code: J01XX09
Manufacturer: Laboratorios Normon, S.A.
-
The medicine is used in adults, as well as in children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections related to these infections. In adults, it is also used to treat bloodstream infections and infections of the tissues lining the heart chambers (including valves) caused by Staphylococcus aureus bacteria.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 500 mg ATC code: J01XX09
Manufacturer: Betapharm Arzneimittel GmbH S.C. Rual Laboratories S.R.L.
-
The medicine is used in adults, children, and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections associated with these infections. In adults, it is also used to treat heart infections (infection of the tissues lining the heart chambers and valves) and bloodstream infections caused by Staphylococcus aureus bacteria.
Dosage form: powder for preparation of solution for injection / infusion
Active substance Dosage daptomycin 350 mg ATC code: J01XX09
Manufacturer: Betapharm Arzneimittel GmbH S.C. Rual Laboratories S.R.L.
-
The medicine is used for the treatment of eye inflammation.
Dosage form: drops, ophthalmic solution
Active substance Dosage dexamethasone sodium phosphate 1 mg/ml ATC code: S01BA01
Manufacturer: Pharmaselect International Beteiligungs GmbH
-
The medicine is used in adults for the symptomatic treatment of overactive bladder conditions, such as urgency, frequency, and urge incontinence.
Dosage form: tablets, prolonged release
Active substance Dosage darifenacin hydrobromide 8.923 mg ATC code: G04BD10
Manufacturer: Aristo Pharma GmbH
-
This medicine is used in adults for the symptomatic treatment of overactive bladder conditions, such as urgency, frequency, and urge incontinence.
Dosage form: tablets, prolonged release
Active substance Dosage darifenacin hydrobromide 17.846 mg ATC code: G04BD10
Manufacturer: Aristo Pharma GmbH
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and clots in other vessels (in people with atrial fibrillation and additional risk), and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.
-
The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in the case of atrial fibrillation and additional risk factors) and for the treatment and prevention of recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 40 kg.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 800 mg ATC code: J05AE10
Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 600 mg ATC code: J05AE10
Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age (weighing more than 40 kg). It helps to reduce the amount of virus in the body and supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 400 mg ATC code: J05AE10
Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infections in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 300 mg ATC code: J05AE10
Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral drugs.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 150 mg ATC code: J05AE10
Manufacturer: Laboratori Fundació Dau Pharmadox Healthcare Ltd. Pharmathen International S.A. Pharmathen S.A.
-
This medicine is used to treat human immunodeficiency virus (HIV) infection in adults and children over 3 years of age and weighing more than 15 kg, who have previously been treated with other antiretroviral medicines.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 75 mg ATC code: J05AE10
Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Ltd. Pharmaten International S.A. Pharmaten S.A.
-
The medicine is used to treat human immunodeficiency virus (HIV) infection in adults and children (over 3 years of age and weighing at least 40 kg). It helps to reduce the amount of virus in the body, which supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 800 mg ATC code: J05AE10
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicine is used in adults and children (above 3 years of age and weighing at least 15 kg) to treat HIV infection. It helps to reduce the amount of virus in the body and supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 600 mg ATC code: J05AE10
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicine is used to treat human immunodeficiency virus (HIV) infections in adults and children over 3 years of age (weighing more than 15 kg) who have previously taken other antiretroviral medicines.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 600 mg ATC code: J05AE10
Manufacturer: LEK Pharmaceuticals d.d.
-
This is an antiretroviral medicine used in adults and children (over 3 years of age and weighing at least 40 kg) for the treatment of human immunodeficiency virus (HIV) infection.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 800 mg ATC code: J05AE10
Manufacturer: LEK Pharmaceuticals d.d., Remedica Ltd, Salutas Pharma GmbH
-
The medicine is used in adults and children over 3 years of age (weighing more than 15 kg) for the treatment of human immunodeficiency virus (HIV) infections. It helps to reduce the amount of virus in the body and supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 150 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
The medicinal product is used in the treatment of human immunodeficiency virus (HIV) infections in adults and children over 3 years of age (weighing more than 15 kg) who have previously been treated with other antiretroviral drugs.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 600 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
The medicine is used in adults and children over 3 years of age (weighing more than 15 kg) to treat HIV infection. It helps to reduce the amount of virus in the body and supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 300 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
This medicine is used to treat human immunodeficiency virus (HIV) infections in adults and children (over 3 years of age and weighing at least 40 kg). Its action consists of reducing the viral load in the body, which supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 400 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
The medicine is used to treat human immunodeficiency virus (HIV) infections in adults and children (over 3 years of age and weighing at least 40 kg). It helps to reduce the amount of virus in the body, which supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 800 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
The medicine is used in the treatment of adults and children above 3 years of age (weighing more than 15 kg) infected with HIV, who have already been treated with other antiretroviral drugs. It helps to reduce the amount of virus in the body and supports the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 75 mg ATC code: J05AE10
Manufacturer: Hormosan Pharma GmbH, Pharmadox Healthcare Ltd., Pharmathen International S.A., Pharmathen S.A.
-
Daruph is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia in whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 79 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
The medicinal product is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children aged 1 year and older. It is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age), and in the lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 63.2 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
The medicine is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in the treatment of lymphoblastic blast crisis (PBSz) in adults for whom previous treatment was not effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 110.6 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
The medicinal product is used in the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents and children (from 1 year of age). It is also used in adults for the blast crisis stage of Ph+ chronic myeloid leukemia in whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 55.3 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
The medicine is used in the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of PBSz, in whom previous treatment was not effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 39.5 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
The medicine is used for the treatment of chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and for the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of CML if previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 15.8 mg ATC code: L01XE06
Manufacturer: Pharmacare Premium Ltd. Zentiva, k.s.
-
This medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in adults in the case of lymphoblastic blast crisis of CML, where previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC code: L01EA02
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the blast crisis phase of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 100 mg ATC code: L01EA02
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children from 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children from 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC code: L01EA02
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC code: L01EA02
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
Dasatinib Eugia is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as to treat lymphoblastic blast crisis of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC code: L01EA02
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in the blast crisis phase of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
It is used in the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in some cases of lymphoblastic blast crisis of CML.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). It is also used in the treatment of blast crisis of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 70 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). It is also used in the treatment of blast crisis of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). In adults, it is also used to treat the lymphoblastoid blast crisis phase of CML if previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 100 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and in the blast crisis phase of CML in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC code: L01EA02
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L.
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (over 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC code: L01EA02
Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd
-
Dasatinib Sandoz is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC code: L01EA02
Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (over 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in patients for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC code: L01EA02
Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults, adolescents, and children (from 1 year of age) for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC code: L01EA02
Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd